Pharmaceutical Middlemen Feel the Squeeze

Lawmakers and the Trump administration are focusing on insurers and pharmacy benefit managers in their push for drug-price transparency.

×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login